Alexandra R Hyler

Dr. Alexandra R Hyler

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AHAlexandra R Hyler
Alexandra R Hyler
NBNicolaas C Baudoin
Nicolaas C Baudoin
MBMegan S Brown
Megan S Brown
MSMark A Stremler
Mark A Stremler
DCDaniela Cimini
Daniela Cimini
ESEva Schmelz
Eva Schmelz
Ovarian cancer cells are exposed to physical stress in the peritoneal cavity during both tumor growth and dissemination. Ascites build-up in metastatic ovarian cancer further increases the exposure to fluid shear stress. Here, we used a murine, in vitro ovarian cancer progression model in parallel with immortalized human cells to investigate how ovarian cancer cells of increasing aggressiveness respond to of fluid-induced shear stress. This biophysical stimulus significantly reduced cell viability in all cells exposed, independent of disease stage. Fluid shear stress induced spheroid formation and altered cytoskeleton organization in more tumorigenic cell lines. While benign ovarian cells appeared to survive in higher numbers under the influence of fluid shear stress, they exhibited severe morphological changes and chromosomal instability. These results suggest that exposure of benign cells to low magnitude fluid shear stress can induce phenotypic changes that are associated with transformation and ovarian cancer progression. Moreover, exposure of tumorigenic cells to fluid shear stress enhanced anchorage-independent survival, suggesting a role in promoting invasion and metastasis.

9 March 2021 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
AHAlexandra R Hyler
Alexandra R Hyler
DHDaly Hong
Daly Hong
RDRafael V. Davalos
Rafael V. Davalos
NSNathan S. Swami
Nathan S. Swami
ESEva Schmelz
Eva Schmelz

19 September 2019 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
VFVahid Farmehini
Vahid Farmehini
WVWalter Varhue
Walter Varhue
ASArmita Salahi
Armita Salahi
AHAlexandra R Hyler
Alexandra R Hyler
JCJaka Cemazar
Jaka Cemazar
NSNathan Swami
Nathan Swami
Objective: Assessing the effectiveness of microfluidic device structures for enabling electrokinetic or acoustic trapping requires imaging of model particles within each device under the requisite force fields. To avoid the need for extensive microscopy, the use of valuable biological samples, and reliance on a trained operator to assess efficacy of trapping, we explore electrical means to identify device geometry variations that are responsible for the poor trapping. Results: Using the example of AC electrokinetic trapping over an insulated channel in a contact-less dielectrophoresis mode, we present an on-chip method to acquire impedance spectra on the microfluidic device for quantifying the parasitic voltage drops. Conclusion: Based on the parasitic voltage drops, device geometries can be designed to maximize fraction of the applied voltage that is available for dielectrophoretic manipulation and the measured on-chip impedance can rapidly inform downstream decisions on particle manipulation.

19 February 2025 in Micromachines
Verified
Journal Article
Open access
PDF file
DTDean E. Thomas
Dean E. Thomas
KKKyle S. Kinskie
Kyle S. Kinskie
KBKyle M. Brown
Kyle M. Brown
LFLisa A. Flanagan
Lisa A. Flanagan
Rafael DavalosRafael Davalos
Rafael Davalos
AHAlexandra R Hyler
Alexandra R Hyler
Conducting detailed cellular analysis of complex biological samples poses challenges in cell sorting and recovery for downstream analysis. Label-free microfluidics provide a promising solution for these complex applications. In this work, we investigate particle manipulation on two label-free microdevice designs using cDEP to enrich E. coli from whole human blood to mimic infection workflows. E. coli is still a growing source of bacteremia, sepsis, and other infections in modern countries, affecting millions of patients globally. The two microfluidic designs were evaluated for throughput, scaling, precision targeting, and high-viability recovery. While CytoChip D had the potential for higher throughput, given its continuous method of DEP-based sorting to accommodate larger clinical samples like a 10 mL blood draw, it could not effectively recover the bacteria. CytoChip B achieved a high-purity recovery of over 98% of bacteria from whole human blood, even in concentrations on the order of <100 CFU/mL, demonstrating the feasibility of processing and recovering ultra-low concentrations of bacteria for downstream analysis, culture, and drug testing. Future work will aim to scale CytoChip B for larger volume throughput while still achieving high bacteria recovery.

18 February 2025 in Electrophoresis
Verified
Journal Article
Closed access
AHAlexandra R Hyler
Alexandra R Hyler
DTDean E. Thomas
Dean E. Thomas
KKKyle S. Kinskie
Kyle S. Kinskie
KBKyle M. Brown
Kyle M. Brown
JDJosie L. Duncan
Josie L. Duncan
RDRafael V. Davalos
Rafael V. Davalos

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
AHAlexandra R Hyler
Alexandra R Hyler
ACAlicia M. Cole
Alicia M. Cole
RBRidi Barua
Ridi Barua
ADAmiran K. Dzutsev
Amiran K. Dzutsev
ESEva Schmelz
Eva Schmelz
Single-cell level investigations such as DNA and RNA sequencing, protein analyses, and phenotypic studies require an input sample with a high rate of viability (>90%). If too many dead cells are present in the input, degraded proteins and ambient DNA or RNA can increase background noise that may lead to missing identification of crucial targets. Since the cost for single-cell sequencing experiments still remains high, it is critical to ensure the input sample is optimized for high viability to ensure cost-effective and reproducible data. Current bead assays or other sample viability enrichment techniques used in preparation for single-cell analyses typically result in a significant sample loss, sometimes sacrificing 80% of the starting sample, and these preparation steps require multiple passes (> 45 minutes time) and costly kits. These beads or kits can be biased and change the cell population, subject cells to unwanted stresses, and diminish sample integrity with the time needed for preparations. Here, we investigate sample cell viability enrichment on the Cyto R1 Platform, a label-free, cell enrichment, sorting, and recovery platform. At the core, the Cyto R1 uses Cyto Chips, microfluidic technologies with electrical fields, to phenotypically enrich and sort various cells based upon cells’ unique physical structures and subcellular features. Thus, the Cyto R1 ensures native cell recovery without any unwanted cell tagging to maximize sample integrity. In this work, a variety of single cell solutions derived from T cell lymphoma tumors, ascites fluid, and organ tissues were enriched for viable cells to obtain a final sample viability over 90%. Additionally, we aimed to achieve a minimum of 50,000 viable cells, a common target for single-cell sequencing, in as rapid a timeframe as possible. In one sample origin tested, murine T cell lymphomas, the average starting viability was 65 ± 6.5%, and the final viability after enrichment on the Cyto R1 Platform was 95.8 ± 1.8%. Similarly, murine ascites cell mixtures were enriched from average viabilities below 55% up to 91.6 ± 4.2%. For all samples tested, >50,000 viable cells were obtained in under 30 minutes. This work demonstrates that the Cyto R1 can effectively and efficiently enrich a variety of starting samples for high viability (>90%) as required for downstream assays and single-cell sequencing. Citation Format: Alexandra R. Hyler, Alicia M. Cole, Ridi Barua, Amiran K. Dzutsev, Eva M. Schmelz. Cyto R1 Platform enriches samples’ viability for single-cell sequencing and downstream assays [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 1687.